Class Action Article

  • File A Talcum Powder Lawsuit: Talcum Powder Ovarian Cancer Lawsuits Talcum Powder Fallopian Tube Cancer Lawsuits Baby  Powder Ovarian Cancer Lawsuits Filed If you or a loved one used talcum powder products and were diagnosed with ovarian cancer, or fallopian tube can...

Class Action News

Drug Class Actions

  • Taxotere Lawyers for Permanent Hair Loss: Taxotere Baldness Lawyers For  Permanent Hair Loss Lawsuits Have you received Taxotere for breast cancer? Taxotere can result in hair loss or baldness  that is permanent. Taxotere  is a chemotherapy drug used for the treatment of breas...

Medical Device Lawsuits

  • Get A Hernia Mesh Lawyer | Hernia Mesh Lawsuits Filed: The hernia mesh lawyers of Class Action Lawyer Network are filing hernia mesh lawsuits for victims of a failed hernia mesh. We have Ethicon, Bard and Cook hernia mesh lawyers. Hernia Mesh Lawsuits Filed  For: Ethicon: Physiomesh Pro...

Posts Tagged ‘Actos’

Dangerous Drugs and Devices Alert, Get Justice Now, Class Action Lawyers

Written by lisaspitzer on . Posted in Drug Lawsuits, Medical Device Lawsuits

Every day we find new drugs and devices with new warnings. Class action lawyers are seeking justice for the injured. We are here to help you. If you have been injured by a dangerous drug or device, or what we call a " bad drug or device " call us for help.

  • AED Heart Device Lawsuits,
  • Actos,
  • Benzene Exposure.,
  • Car Seat Failure,
  • DePuy Hip Replacement Problems,
  • Fosamax Lawsuits,
  • Mirena IUD for Uterine perforation,
  • GranuFlo, and NaturaLyte,
  • Carbon Dioxide poisoning,
  • Medtronic Infuse Bone Graft, Spinal Medical Device
  • Sketcher Sneakers,
  • Mesothelioma,
  • Insurance Fraud claims,
  • QUi Tam,
  • NuvaRing,
  • Pradaxa,
  • Transvaginal Surgical Mesh Lawsuit,
  • Pelvic Mesh lawyers,
  • Bladder Sling lawyer,
  • Tramatic Brain Injury lawyer,
  • Stryker Rejuvinate Hip Replacement lawyer, ABG II Recalls
  • YAZ class action,
  • Yasmin,
  • Meningitis from Steroid Injections,

 

 

 

Texas Class Action Lawyers, Multi District Litigation lawyers

Written by Class Action Lawyer on . Posted in Class MDL Class Action News, Texas Multidistrict Litigation Lawyers

What is a Texas Multi District Litigation?

Multidistrict litigation is a procedure utilized in the federal court system to transfer to one federal judge all pending civil cases of a similar type filed throughout the United States. The decision whether cases should be transferred is made by a panel of seven federal judges appointed by the Chief Justice of the United States Supreme Court. The Judicial Panel on Multidistrict Litigation meets periodically to review requests that cases be consolidated for pretrial matters pursuant to 28 U.S.C. § 1407

Class Action Vs Multi District Litigation

class actions may be transferred to an MDL consolidation in the same manner as single plaintiff cases. However, for cases to be treated as proper for an MDL consolidation the Panel must find they one or more common questions of fac t. Since commonality is also an required element for a class action, class actions are frequently litigated in MDL proceedings.

What is a Class Action?

a class action, a class suit, or a representative action is a form of lawsuit in which a large group of people collectively bring a claim to court and/or in which a class of defendants is being sued. Class actions are commonly referred to as class action suits

Current most sought  Multi District Litigations In the news for dangerous Drugs and Medical Devices

  • Yaz,
  • Yasmin,
  • Vaginal mesh,
  • DePuy Hip Replacement,
  • Actos,
  • Pradaxa.

Yasmin / YAZ Multidistrict Litigation (MDL) Motion Filed Late July 2009

Some types of Texas  cases naturally lend themselves to MDL, such as those involving:

  • dangerous drugs, medical devices,  products liability claims
  • airplane crashes,
  • securities fraud,
  • intellectual property infringement, and
  • employment practices,.

 

Acotos MDL, Actos Bladder cancer Victims to Get Justice, Actos Lawyers Ready

Written by Class Action Lawyer on . Posted in Drug Warnings, Louisiana Multidistrict Litigation Lawyers, Multidistrict Lawsuit News

A Mutli District litigation is currently underway to help the victims of Actos. Actos has been shown to cause Bladder cancer in long term use, usually over two years. Bladder cancer is fatel. Actos is prescribed for adult onset diabetes which usually is found in Older seniors or minority groups due to age or years of poor dietary habits. Victims of Actos should contact an experienced MDL litigator to file the case at the state level. The case is then transfered to the MDL in Louisiana. A local attorney is not needed. What you will need i an experienced Actos MDL lawyer.

<

IN RE: Actos (Pioglitazone) Products Liability Litigation

United States District Court for the Western District of Louisiana

The Honorable Rebecca F. Doherty, Presiding.

Class Action Lawyer Network Louisiana MDL division Actos Lawyers are accepting cases for this Louisiana Actos MDL

         

Multidistrict litigation is litigation comprised of multiple civil cases involving one or more common questions of fact, but the cases are pending in different districts. Such actions may be transferred to any single district for coordinated or consolidated pretrial proceedings. These transfers are made by the MDL authorized by 28 U.S.C. 1407. Actions will be transferred for the convenience of the parties and witnesses and to promote the just and efficient conduct of such actions. More information on multidistrict litigation can be obtained from the United States Judicial Panel on Multidistrict Litigation at

On December 29, 2011, the United States Judicial Panel on Multidistrict Litigation transferred 11 civil action(s) to the United States District Court for the Western District of Louisiana for coordinated or consolidated pretrial proceedings pursuant to 28 U.S.C. 1407, assigned to the Honorable Rebecca F. Doherty.

Each of these actions alleges claims arising from the use of Actos, a prescription medication approved for use in the treatment of type 2 diabetes.  Plaintiffs allege that individuals who use Actos face an increased risk of developing bladder cancer. Plaintiffs further allege that the defendants concealed their knowledge of this risk and failed to provide adequate warnings to consumers and the health care community.  Defendants deny all allegations of fault.

Actos Lawyers, Actos News, Actos Bladder Cancer Victims

Written by Class Action Lawyer on . Posted in Louisiana Multidistrict Litigation Lawyers

Actos has warnings for bladder cancer. Actos cases have been consolidated and Actos Lawyers are accepting clients.

The judge overseeing lawsuits alleging Takeda Pharmaceutical Co. (4502)’s Actos diabetes medicine causes cancer appointed 19 plaintiffs’ lawyers to manage litigation involving U.S. claims.

Takeda, Asia’s biggest drugmaker, may face as many as 10,000 claims that Actos causes bladder cancer after U.S. regulators found last year the drug was linked to the disease. Federal lawsuits against the drugmaker were consolidated before U.S. District Judge Rebecca Doherty in Lafayette, Louisiana, in December. The first hearing on the cases is set for March 22, according to court filings.

“The court has determined to effect the selection of lead counsel, liaison counsel and plaintiffs’ executive and steering committees before the March 22nd-23rd status conference,” Doherty said in a March 12 note posted on the court’s website.

The lawsuits claim patients who use Actos, a prescription drug approved to treat type 2 diabetes, face increased risks of developing bladder cancer. The plaintiffs also claim that Takeda and co-defendant Eli Lilly & Co., based in Indianapolis, withheld information about the risk and failed to provide adequate warnings.

Takeda pulled Actos, its top-selling drug, off the market in Germany and France last year after it was linked to an increased cancer risk. The medication had sales of 387.9 billion yen ($4.8 billion) last fiscal year, 27 percent of the Osaka, Japan-based company’s revenue.
Lead Counsel

“Given that litigation is pending, we can’t comment,” Jocelyn Gerst, a U.S.-based spokeswoman for Takeda, said in a telephone interview about the selection of the plaintiffs’ group.

Doherty named attorneys Richard Arsenault and Paul Pennock as lead plaintiffs’ counsel in the case and also appointed them to the executive committee, along with lawyers Mark Robinson and Hunter Shkolnik.

Arsenault, a products-liability lawyer based in Alexandria, Louisiana, served as one of the lead lawyers in consolidated cases filed against Merck & Co. (MRK) over its Vioxx painkiller that resulted in a $4.85 billion settlement in November 2007.

Pennock, a New York-based attorney, was one of the lawyers leading the consolidated suits against AstraZeneca Plc (AZN) over its Seroquel antipsychotic drug. The London-based drugmaker agreed last year to pay a total of about $350 million to resolve patients’ claims that the drug caused diabetes.
Steering Committee

The Los Angeles-based Robinson, who has won multimillion- dollar jury awards against carmakers such as Ford Motor Co., is a co-lead counsel in sudden-acceleration lawsuits against Toyota Motor Corp. (7203)

Shkolnik, based in New York City, served as a member of the plaintiffs’ steering committee in lawsuits against Medtronic Inc. (MDT) over flawed heart defibrillators. The cases later settled for more than $114 million.

Other lawyers named to the plaintiffs’ steering committee in the Actos cases include Mark Lanier, a Texas-based lawyer who won the first jury award against Whitehouse Station, New Jersey- based Merck in the Vioxx litigation, and Chris Seeger, a New Jersey-based attorney who also won a verdict against Merck on behalf of Vioxx users.

The judge also named Andy Birchfield, an Alabama-based lawyer who helped negotiate the $4.85 billion Vioxx settlement, and Vance Andrus, a Lafayette-based lawyer who was one of the lead counsels in cases against GlaxoSmithKline Plc (GS) over its Avandia diabetes drug. The London-based drugmaker has agreed to pay more than $700 million to resolve claims that Avandia caused heart attacks and strokes in users.

The lawsuits are consolidated in In Re: Actos Products Liability Litigation, 11-2299, U.S. District Court, Western District of Louisiana (Lafayette).

Johnson and Johnson Again, Now More Tylenol Recalls

Written by Class Action Lawyer on . Posted in Class MDL Class Action News

Johnson and Johnson's Tylenol has had FDA warnings for overdose leading to Liver damage. Just a part of the long line of J & J recalls and FDA warnings. Class Action Lawyer network is accepting cases for Liver damge from Tylenol.Johnson & Johnson said Friday it is recalling more Tylenol.

Now 574,000 bottles of grape-flavored Infants Tylenol is being recalled  because a new dispenser malfunctioned when used by many parents. The redesigned system with a syringe and flow restrictor, it was hoped, would prevent overdosing.

The manufacturing part of t the  facility in question  was shut down in April 2010 because of several problems, including musty smells and metal particles in medicines, that led to dozens of recalls. J&J officials  proclaim  they have spent $100 million to fix the problems, but will need approval from a federal court judge and the U.S. Food and Drug Administration to resume production. The McNeil plants in Lancaster and Puerto Rico continue to operate, but under closer FDA scrutiny. There have been warnings for Tylenol causing liver damage and documented cases.  If you or a loved one has liver damge due to Tylenol causing severe debilitation or wrongful death call our Tylenol lawyers today.

Statute of Limitations By State, Class Action Lawyers, Multi District Litigations

Written by Class Action Lawyer on . Posted in Class Action Articles

Statutes of Limitations for the 50 States (and the District of Columbia)

State statute Written Contract oral contract Injury property damage
Alabama Ala. Code § 6-2-2 et seq. * 6 6 2 6
Alaska Alaska Stat. § 09.10.010 et seq. 3 3 2 6 (real property); 2 (personal property)
Arizona Ariz. Rev. Stat. Ann. § 12-541 et seq. 6 3 2 2
Arkansas Ark. Code Ann. § 16-56-101 et seq. 5 3 3 3
California Cal. Civ. Proc. Code § 312 et seq. 4 2 2 3
Colorado Colo. Rev. Stat. § 13-80-102 et seq. 6 6 2 2
Connecticut Conn. Gen. Stat. Ann. § 52-575 et seq. 6 3 3 2
Delaware Del. Code Ann. tit. 10, § 8101 et seq. 3 3 3 2
District of Columbia D.C. Code § 12-301 et seq. 3 3 3 3
Florida Fla. Stat. Ann. § 95.011 et seq. 5 4 4 4
Georgia Ga. Code Ann. § 9-3-20 et seq. 6 4 2 4
Hawaii Haw. Rev. Stat. § 657-1 et seq. 6 6 2 2
Idaho Idaho Code § 5-201 et seq. 5 4 2 3
Illinois 735 Ill. Comp. Stat. 5/13-201 et seq. 10 5 2 5
Indiana Ind. Code Ann. § 34-11-2-1 et seq. 10 6 2 6 (real property); 2 (personal property)
Iowa Iowa Code Ann. § 614.1 et seq. 10 5 2 5
Kansas Kan. Stat. Ann. § 60-501 et seq. 5 3 2 2
Kentucky Ky. Rev. Stat. Ann. § 413.080 et seq. 15 5 1 5 (real property); 2 (personal property)
Louisiana La. civil code § 3492 et seq. 10 10 1 1
Maine Me. Rev. Stat. Ann. tit. 14, § 751 et seq. 6 6 6 6
Maryland Md. Courts & Jud. Proc. Code Ann. § 5-101 et seq. 3 3 3 3
Massachusetts Mass. Ann. Laws ch. 260, § 1 et seq. 6 6 3 3
Michigan Mich. Comp. Laws § 600.5801 et seq. 6 6 3 3
Minnesota Minn. Stat. Ann. § 541.01 et seq. 6 6 6 6
Mississippi Miss. Code. Ann. § 15-1-1 et seq. 6 3 3 3
Missouri Mo. Rev. Stat. § 516.097 et seq. 5 5 5 5
Montana Mont. Code Ann. § 27-2-2021 et seq. 8 5 3 2
Nebraska Neb. Rev. Stat. § 25-201 et seq. 5 4 4 4
Nevada Nev. Rev. Stat. Ann. § 11.010 et seq. 6 4 2 3
New Hampshire N.H. Rev. Stat. Ann. § 508:1 et seq. 3 3 3 3
New Jersey N.J. Stat. Ann. § 2a:14-1 et seq. 6 6 2 6
New Mexico N.M. Stat. Ann. § 37-1-1 et seq. 6 4 3 4
New York N.Y. Civ. Prac. Laws & Rules § 201 et seq. 6 6 3 3
North Carolina N.C. Gen. Stat. § 1-46 et seq. 3 3 3 3
North Dakota N.D. Cent. Code § 28-01-01 et seq. 6 6 6 6
Ohio Ohio Rev. Code Ann. § 2305.03 et seq. 15 6 2 4
Oklahoma Okla. Stat. Ann. tit. 12, § 91 et seq. 5 3 2 2
Oregon Or. Rev. Stat. § 12.010 et seq. 6 6 10 6
Pennsylvania 42 Pa. Cons. Stat. Ann. § 5501 et seq. 4 4 2 2
Rhode Island R. I. Gen. Laws § 9-1-12 et seq. 10 10 3 10
South Carolina S.C. Code Ann. § 15-3-510 et seq. 3 3 3 3
South Dakota S.D. Codified Laws Ann. § 15-2-1 et seq. 6 6 3 6
Tennessee Tenn. Code Ann. § 28-3-101 et seq. 6 6 1 3
Texas Tex. Civ. Prac. & Rem. Code § 16.001 et seq. 4 4 2 2
Utah Utah Code Ann. § 78-12-22 et seq. 6 4 4 3
Vermont Vt. Stat. Ann. tit. 12, § 461 et seq. 6 6 3 3
Virginia Va. Code Ann. § 8.01-228 et seq. 5 3 2 5
Washington Wash. Rev. Code Ann. § 4.16.005 et seq. 6 3 3 3
West Virginia W. Va. Code § 55-2-1 et seq. 10 5 2 2
Wisconsin Wis. Stat. Ann. § 893.01 et seq. 6 6 3 6
Wyoming Wyo. Stat. § 1-3-102 et seq. 10 8 4 4

 

Lawyers Still Accepting Actos Cases, Actos Causing Bladder Cancer

Written by Class Action Lawyer on . Posted in Class MDL Class Action News

Lawyers Still Accepting Actos Cases as First Hearing Set to Begin. If you or a loved one has been diagnosed with bladder cancer from Actos contact us for an Actos lawyer today.

10,000 Actos lawsuits are expected to be filed
Orlando, FL (PRWEB) February 21, 2012
A federal judge tasked with overseeing the litigation over whether a popular diabetes drug caused bladder cancer in hundreds of patients is moving quickly to expedite the legal process for both sides.
While those who have already filed an Actos lawsuit are one step closer to having their day in court, lawyers are still helping those who are just coming forward with side effects.
On Monday, February 13, U.S. District Judge Rebecca Doherty issued an order scheduling a pretrial status conference in the Actos litigation for March 22, 2012. The hearing will give representatives of the drug manufacturer and those of patients alleging bladder cancer from the drug a chance to discuss trial preparation and whether any progress has been made in reaching a settlement.
After the hearing, Judge Doherty will also appoint lead counsel in the consolidated cases from her bench in Lafayette, Louisiana.
Doherty was originally assigned to dozens of the lawsuits in Multi-District Litigation following an order by the U.S. Judicial Panel on Multidistrict Litigation in December. She now presides over approximately 150 cases and lawyers expect thousands more may be filed before litigation is complete. The pending case is In Re: Actos Products Liability Litigation, MDL 2299, U.S. District Court, Western District of Louisiana (Lafayette).
Lawyers with the Actos Resource Center have responded to hundreds of inquiries from those who have taken Actos and expect many more will come forward due to the popularity of the drug.
On June 15, 2011, the FDA issued a warning that taking Actos for longer than one year could heighten the risk of bladder cancer. Approved by the FDA in 1999, Actos had become one of the most popular diabetes drugs in the world after rival Avandia was linked to heart problems.
The warning came after a study of 155,000 patients over four years by the French Medicines Agency showed taking Actos could increase the occurrence of bladder cancer by up to 40%.
Authorities in France and Germany quickly banned sales of the drug. However, it remains on the market in the United States.
Now, according to a Bloomberg article published December 1, 2011, drug makers Takeda Pharmaceuticals and Eli Lilly could face as many as 10,000 lawsuits from those stricken with bladder cancer after taking Actos.
On Tuesday, Takeda released a statement saying "Takeda is confident in the therapeutic benefits of Actos and its importance as a treatment for type 2 diabetes. As a science and evidence-based company, Takeda firmly stands behind the substantial data available confirming the positive risk/benefit profile of Actos, which includes twelve years of clinical and patient experience with the product."
For more information on the side effects, FDA warnings and litigation associated with Actos, visit ActosCancer.com.

Class Action Lawyer Netrwork Actos Lawyers are accepting cases for bladder cancer form Actos. These are part of an Actos Multi District litigation.

What is Class Action Lawyer Network ?

Written by Class Action Lawyer on . Posted in Class Action Articles

Class Action Lawyer Network is a nationwide group of lawyers experienced in both class action and multi district litigation lawsuits?

What is a class Action?

In law, a class action, a class suit, or a representative action is a form of lawsuit in which a large group of people collectively bring a claim to court and/or in which a class of defendants is being sued. Class actions are commonly referred to as "class action suits,"

What is a multi district litigation?

Multidistrict litigation is a procedure utilized in the federal court system to transfer to one federal judge all pending civil cases of a similar type filed throughout the United States. The decision whether cases should be transferred is made by a panel of seven federal judges appointed by the Chief Justice of the United States Supreme Court. The Judicial Panel on Multidistrict Litigation meets periodically to review requests that cases be consolidated for pretrial matters pursuant to 28 U.S.C. § 140  Claimants are not treated as a class but on a individual basis for theor injuries.

How are these lawyers different?

The memeber team of Class Action Lawyer Network are attorneys skilled in both class actiona and Mutli district litigations. They are lead lawyers. Your case is not referred out to another firm. Every team member has a liason in their office with knowledge of the product, drug or medical device you have been injured by. They can answer questions, give you the tlc you need and are available to keep you updated and respond to any future concerns you may have. You always know where your case is. Your file stays where you thought it was.  All memebers of Class Action lawyer Network are trial lawyers. They will be there fighting for you. MDL's and Class action s are usually fought in federal court.  They very rarely stay in your state where you may have received the injury. The lawyers and the manufacturers agree on the court where the cases are to be heard and these cases become "consolidated" in that court room. You need a lawyer whose "feet will be on the ground" in that court room. You will not be speaking to a "screener" but, a trained liason with experience in all MDL and Class Action litigations including the side effect complications, and manufactureres who you have been injured by.

Current Dangerous Drugs, Medical Devices and MDL's or Class Actions we cover Include:

  •     Accutane,
  •     Actos,
  •     Aranasp,
  •     Aredia,
  •     Ambien
  •     Amnesteem
  •     Anticonvulsant, Anti-seizure & Antiepileptic Drugs: Cleft Lip or Cleft Palate Birth Defects
  •     Anti depressants causing birt defects
  •     Asbestos Mesothelioma
  •     Advair
  •     Avandia: Heart Attacks
  •     Arava: Liver Injury
  •     Baycol
  •     Bextra
  •     Botox
  •     Bovena
  •     Byetta
  •     Chantix
  •     Carbamazepine
  •     Cefepime
  •     Celebrex
  •     Cialis
  •     Cipro
  •     Cochlear ear implant
  •     CooperVision contact lenses
  •     Costa Concordia Victims
  •     Crestor
  •     Cytotec
  •     Claravis
  •     Darvocet: Heart Attacks & Arrhythmia
  •     Darvon: Heart Attacks & Arrhythmia
  •     Depakote
  •     Digitek
  •     Duract
  •     Duragesic
  •     Effexor Birth Defects
  •     Ephedra
  •     Epogen
  •     Femara
  •     Fen-Phen
  •     Fentanyl
  •     Fluorquinolone
  •     Fixodent: Zinc Toxicity & Neuropathy
  •     Fosamax: Osteonecrosis
  •     Gardasil
  •     Gadolinium
  •     Gleevec
  •     Generic Keppra (Levetiracetam):  Seizures
  •     Hismanal
  •     Heparin
  •     Hydroxycut
  •     Isotretinoin
  •     Ketek
  •     Lamisil
  •     Leukine
  •     Levitra
  •     Levaquin
  •     Lotronex
  •     Mirena birth control devices
  •     Meridia
  •     Mifeprex
  •     Mirapex
  •     Mobic
  •     Ocella Birth Control Pills & Oral Contraceptives
  •     Ortho-Evra
  •     Paxil Birth Defects
  •     Permax
  •     Phenergan
  •     Pondimin
  •     Posicor
  •     Prempro
  •     Prilosec
  •     Procrit
  •     Propecia
  •     Propulsid
  •     Provigil
  •    Poligrip: Zinc Toxicity & Neuropathy
  •     Plavix
  •     Propoxyphene: Heart Attacks & Arrhythmia
  •     Prozac: Birth Defects
  •     Quinine
  •     Qui Tam
  •     Reglan (Metoclopramide): Tardive Dyskinesia
  •     Raplon
  •     Raptiva
  •     Raxar
  •     Redux
  •     Rezulin
  •     Risperdal
  •     Ritalin
  •     Rituxan
  •     Seldane
  •     Seroquel
  •     Sotret
  •     Tequin
  •     Trasylol
  •     Tys (Tysabri)
  •     Topamax & Topiramate: Cleft Lip or Cleft Palate
  •     Upsher: Smith Recall
  •     Viagra
  •     Vioxx
  •     Vytorin
  •     Whistleblowers
  •     Xolair
  •     Yasmin
  •     YAZ
  •     Zelnorm
  •     Zencore-Tabs
  •     Zicam
  •     Zometa
  •     Zyprexa
  •     Zicam: Loss Of Smell or Taste
  •     Zocor
  •     Zoloft

   

ORTHOPEDIC AND MEDICAL DEVICES

    Animas Insulin Pump
    DePuy ASR Hip Implants
    Depuy Pinnacle Hip Implants
    Smith & Nephew Knee Implant
    Stryker Hip Implants
    Zimmer Duram Cup Hip Replacements
    Zimmer NexGen Knee Implant

VAGINAL MESH MANUFACTURERS
Johnson & Johnson

    Ethicon TVT
    Gynecare TVT
    Gynemesh PS
    Prolene Polypropylene Mesh Patch
    Secur

Bard

    Avaulta Plus BioSynthetic Support System
    Avaulta Solo Synthetic Support System
    Faslata Allograft
    Pelvicol Tissue
    PelviSoft Biomesh
    Pelvitex Polypropylene Mesh

American Medical Systems or AMS
SPARC
Boston Scientific

    Advantage Sling System
    Obtryx Curved Single
    Obtryx Mesh Sling
    Prefyx Mid U Mesh Sling System
    Prefyx PPS System  

Please note new MDL litigations and class actions are added weekly so check back. This may not be a complete list. Contact Class Action lawyer Network to see if we are handling any MDL, Class Action or dangerous drug and medical device litigation. If you are a victim of bad drugs or medical devices, you need an experienced attorney who provides effective and aggressive counsel.

What is a Multidistrict litigation or MDL

Written by Class Action Lawyer on . Posted in Class MDL Class Action News

What is a multidistrict litigation?

Multidistrict litigation is a specific procedure used in the federal court system to transfer to one federal judge all pending civil cases of a similar type. These lawsuits are typically filed throughout the United States. However it is usually in the best interest of the litigants to have these cases consolidated under one Judge in one district especially if a favorable judge is located.  This decision   is made by a panel of seven federal judges appointed by the Chief Justice of the United States Supreme Court. When a judge gets federal cases assigned, this is known as the "transferee judge." Judges throughout the United States who send cases to the MDL judge are know as the "transferor judges" or "transferor courts."

What types of cases are best presented as a  multidistrict litigation ?

This type of litigation works well for product liability claims involving medical devices or prescription drugs. For example, if there are several lawsuits against the manufacturer of a prescription drug because it was known to cause serious side effects that were not disclosed, it would be litigated in one court by one judge. An example would be Actos that causes bladder cancer. The bladder cancer is a specific complication affecting a group of people who have taken Actos. The Actos MDL is a consolidation of all federal lawsuits alleging Actos caused bladder cancer into one court for pretrial precedings. MDLs are often created in cases where pharmaceutical companies are sued by numerous individuals asserting similar injuries. Other drugs with cases proceding in MDLs include, Yaz,Yasmin and Avandia. Multidistrict litigation works well for large, complex cases that involve one or more common issues of fact. Here are some examples of common issues of fact that might warrant the formation of an MDL:

  •     Does a certain pharmaceutical drug cause strokes or liver cancer?
  •     Was an airplane crash caused by a defective braking system?
  •     Were many people injured by a specific malfunction by a specific automobile manufacturer ?

A growing number of women from around the country who are plaintiffs in transvaginal mesh litigation have a court date of Wednesday, January 26 in Miami. The Judicial Panel on Multidistrict Litigation (MDL)  is set to hear requests by plaintiff attorneys to have thousands of defective mesh lawsuits consolidated in the same federal court.

Kugel Mesh multidistrict litigation was filed in federal Rhode Island court on behalf of thousands of individuals alleging injury by the hernia repair patch. He additionally serves as liaison counsel for the nearly 2, 000 Composix Kugel Mesh lawsuits consolidated in Rhode Island state court.

The Yaz multi district litigation cases that have been taking place in the Southern Dsitrict of Illinois were set to see their first bellwether trials happen on the 12th of January, 2012.n However, on the final day of 2011, Judge David R. Herndon, the presiding judge in the Yaz multi district litigation cases, announced that rather than immediately proceeding with bellwether trials he would implement mediation in order to hopefully bring about Yaz pre-trial settlements for at least some plaintiffs.

Overview of Multidistrict Litigation

Multidistrict litigation will only work in cases where there is at least one fact that the cases have in common. In the previous example, the one fact that would be in common is that a particular prescription drug had serious undisclosed side effects. it must be specific.

Is a multidistrict litigation the same thing as a class action?

No. Although class actions may be transferred to an MDL consolidation in the same manner as single plaintiff cases. However, for cases to be treated as proper for an MDL consolidation the Panel must find one or more common questions of fact. Since commonality is also a required element for a class action, class actions are frequently litigated as MDL proceedings.

What happens to a lawsuit after it is transferred to a federal judge by the Panel?

Generally, the transferee court (the MDL court) will set standing orders or pretrial orders informing the lawyers involved of the ground rules, deadlines and procedures the court expects the litigants to follow. Steering committees may be appointed to manage the substance of the litigation and the discovery of facts. In theory, discovery and case management by the MDL court should allow completion of pretrial matters, then the case must be remanded back to the transferor case for trial. The only cases that would not be remanded are those cases originally filed in the court with the MDL judge is seated. In practice, many cases sent to an MDL court are settled at some point in time during the pretrial proceedings.

The Judicial Panel on Multidistrict Litigation is located in Washington, DC at the following address:
Thurgood Marshall Federal Judiciary Building
One Columbus Circle, NE
Room G-255, North Lobby
Washington, DC 20002-8004

The hours of operation are 9:00 a.m. to 4:00 p.m.

Telephone: (202) 502-2800
Facsimile: (202) 502-2888 (24 hours)

What Kinds of Cases Are Subject to Multidistrict Litigation?

Multidistrict litigation works well for large, complex cases that involve one or more common issues of fact. Here are some examples of common issues of fact that might warrant the formation of an MDL:

    Does a certain pharmaceutical drug cause brain damage?
    Was an airplane crash caused by a defective braking system?

Some types of cases naturally lend themselves to MDL, such as those involving:

  •     dangerous drugs, medical devices, and other products liability claims
  •     airplane crashes
  •     securities fraud
  •     intellectual property infringement, and
  •     employment practices.

Current MultiDistrict Litigation news

Oregon Resident’s Levaquin Lawsuit Joined Multidistrict Litigation

The antibiotic Levaquin has been associated with such Levaquin side effects as Achilles heel Levaquin tendon ruptures. In a recent lawsuit, plaintiff Dianne K. Eccles, represented by her Levaquin lawyer, claims to have experienced a tendon rupture in her shoulder.

Shay Morrigan | January 3rd, 2012 | Posted in Levaquin Lawsuit News, Multidistrict Litigation

Manufacturer Calls for Transvaginal Mesh Multidistrict Litigation
Shay Morrigan | December 12th, 2011 | Posted in Vaginal Mesh Lawsuit News

American Medical Systems (AMS), one of the makers of vaginal mesh products, has called for transvaginal mesh multidistrict litigation (MDL). The medical device company filed a motion on November 23, 2011 with the U.S. Judicial Panel on Multidistrict Litigation (JPML) to consolidate cases whose plaintiffs allege transvaginal mesh complications for more efficient and cost-effective pretrial proceeding

If you were injured and feel it is a possible MDL contact class action lawyer Network Today

 

New Actos Drug Delayed By FDA, Actos and Bladder Cancer

Written by Class Action Lawyer on . Posted in Drug Warnings

Following Actos Warning, FDA Delays Review of New Actos Combined Drug

Following Actos Warnings, FDA Delays Review of New Takeda Diabetes Drug. As is known Actos is known to cause bladder cancer in Type 2 Diabetics with long term use.

With  Takeda Pharmaceuticals already facing many  Actos lawsuits, the U.S. Food and Drug Administration has decided to delay its review of a new type 2 diabetes drug being developed by Takeda Pharmaceutical Company. July 2011, Takeda re-filed an application to have the drug approved by the FDA and eventually have the drug made available to the public. The new data submitted to the FDA includes information about a cardiovascular outcomes trial. The new drug would be the first in the United States to have both a thiazolidinedione and a DPP-4 inhibitor in a single pill. Currently, Aloglitin is sold in other countries and has been approved by some regulators overseas

The U.S. Food and Drug Administration has notified drug partner Takeda Pharmaceuticals that review of investigational diabetes drug alogliptin has been delayed and an approval decision is now expected by April 25, 2012. The delay also affects the fixed-dose combination drug alogliptin/pioglitazone. Regulators had previously expected to make a decision by Jan. 25, 2012.

According to a release from the company, the FDA has decided to pause the review of the investigative type 2 diabetes therapy alogliptin as well as the combination medication alogliptin/pioglitazone. Pioglitazone is the active chemical in the brand name medication Actos.

With the delay having been announced, the new Prescription Drug User Fee Act (PDUFA) action date has reportedly now been set for April 25, 2012, after the federal agency initially assigned a date of January 25, 2012, according to the release from Takeda.

Despite the delay, David Recker, senior vice president of clinical science for Takeda Global Research & Development Center in the U.S., said in a statement that the company still supported the medication's effectiveness.

"Takeda is confident in alogliptin and alogliptin/pioglitazone as potential therapeutic options for the millions of patients living with type 2 diabetes," Recker noted. "We will work closely with the FDA to determine the appropriate next steps, and are dedicated to continuing our efforts to bring these important therapies to market in the U.S."

In the release, the company disclosed that alogliptin is a highly selective dipeptidyl peptidase IV inhibitor (DPP-4i) designed to treat patients suffering from type 2 diabetes when supplemented with the proper diet and exercise.

The drug reportedly works by slowing the inactivation of incretin hormones GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic peptide), which are instrumental in the regulation of blood sugar levels, the company said.

Takeda also added that it has not adjusted its fiscal outlook as a result of the delay in the drug's review, according to the release.

Still, the Japanese drugmaker has been hit hard by the recent spate of Actos lawsuits stemming from Actos warnings being handed down in the U.S. and Europe. Actos, which is also designed to treat patients with type 2 diabetes, has been linked in studies to the potential increased risk of bladder cancer, particularly among patients who have been using the medication for an extended period of time.

As a result of these Actos warnings that have been handed down by the FDA and the European Medicines Agency, Takeda now faces a number of lawsuits across the U.S., and the drugmaker recently experienced a dip in first-half operating profit.

According to Reuters, the requests from the European Medicines Agency and the FDA to add warnings to the medication's labels have had a significant impact on Actos' sales. Sales of the drug fell 13 percent in the six month-period ending September 30. This, coupled with the strong yen, has significantly dented Takeda's profits.

Doctors and patients are becoming increasingly wary of the medication as the number of Actos lawsuits pile up. Thus far, there have been lawsuits filed in states such as Illinois and Louisiana, with plaintiffs often claiming the drugmaker purposely concealed the bladder cancer side effects of the drug at the expense of patients.

While these Actos lawsuits largely center on the risk of bladder cancer, Actos has also been linked to the eye disease macular edema, which is a leading cause of blindness in older adults, according to reports.

ACTOS can cause your body to keep extra fluid (fluid retention), which leads to swelling (edema) and weight gain. Extra body fluid can make some heart problems worse or lead to heart failure. A new study presented in June at the American Diabetes Association’s (ADA) annual meeting suggested that Actos can also lead to vision loss or blindness. Was this really new information or not? I did a little bit more research on Actos and blindness and was shocked to see that back in April 2009, the American Journal of Ophthalmology also posted a “recent study” where nearly 1,000 patients developed Diabetic Macular Edema (DME) after taking Actos. Even more shocking was a 2003 study that showed results of a retrospective study that also indicated that Actos could result in DME. According to that article, presented at the annual meeting of the American Academy of Ophthalmology, patients in that study had macular edema.

Actos is a member of a class of drugs known as thiazolidinediones, which have been linked to bladder cancer,” the US Drug Watchdog said in a released statement. “Actos side effects include increased risk of congestive heart failure, and an increased risk for bladder cancer.

 Network Actos Helpline has been taking calls from people with signs of bladder cancer form Actos as well as families for Wrongful death of a loved one from bladder cancer due to Actos. Actos lawyers are filing lawsuits against TAKEDA Pharmaceuticals for Actos. In light of complications from Actos Takeda appears to be taking a very ambitious step with this new drug. If approved Ibelieve it will be a very hard sell to physicians given the warnings for Actos. If you or a loved one has complications due to Actos contact the Actos Helpline

Class Action lawyer Network Actos lawyers re filing Lawsuits on behalf of clients with complications from Actos